[Form 4] DIVERSIFIED HEALTHCARE TRUST Insider Trading Activity
Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ: DHC), reported a sale of 15,226 common shares on 09/16/2025 at a price of $4.37 per share. The filing lists 415,156.55 shares as his direct beneficial ownership following the transaction and indicates an indirect interest of 23,250,019 shares held by ABP Trust, for which Mr. Portnoy is sole trustee; he disclaims beneficial ownership except to the extent of his pecuniary interest. The filing explains the sale code as F, reflecting withholding of shares to satisfy a tax liability arising from vesting. The Form 4 was signed on 09/18/2025.
Adam D. Portnoy, direttore della Diversified Healthcare Trust (NASDAQ: DHC), ha segnalato la vendita di 15.226 azioni ordinarie il 16/09/2025 al prezzo di $4.37 per azione. La dichiarazione mostra 415.156,55 azioni come sua proprietà diretta beneficiaria dopo la transazione e indica un interesse indiretto di 23.250.019 azioni detenuto da ABP Trust, per le quale il signor Portnoy è unico fiduciario; egli disconosce la proprietà benefica salvo in quanto riguarda il proprio interesse pecuniario. La dichiarazione spiega il codice di vendita come F, che riflette la trattenuta di azioni per soddisfare un obbligo fiscale derivante dalla vestizione. Il Form 4 è stato firmato il 18/09/2025.
Adam D. Portnoy, director de Diversified Healthcare Trust (NASDAQ: DHC), informó la venta de 15.226 acciones comunes el 16/09/2025 a un precio de $4.37 por acción. La declaración señala 415.156,55 acciones como su propiedad directa y beneficiosa tras la operación e indica un interés indirecto de 23.250.019 acciones en ABP Trust, del cual el Sr. Portnoy es el fiduciario único; él renuncia a la propiedad beneficiosa salvo en la medida de su interés pecuniario. La declaración explica el código de venta como F, que refleja la retención de acciones para satisfacer una obligación tributaria derivada de la vesting. El Form 4 fue firmado el 18/09/2025.
Adam D. Portnoy, Diversified Healthcare Trust(NASDAQ: DHC)의 이사로, 15,226주의 일반주를 2025-09-16에 매도했다고 보고했습니다. 주당 매매가 $4.37입니다. 보고서에 매매 이후 그의 직접적 유익소유로 415,156.55주가 기재되었으며, 포트노이가 단독 수탁자인 ABP 트러스트가 보유한 간접적 이해관계 23,250,019주가 표시됩니다. 그는 재정적 이해관계 범위 밖에서 실질적 소유권을 포기합니다. 보고서는 매도 코드를 F로 설명하는데, 이는 과세 부채를 충당하기 위해 주식을 보류했음을 나타냅니다. 양식 4는 2025-09-18에 서명되었습니다.
Adam D. Portnoy, administrateur de Diversified Healthcare Trust (NASDAQ: DHC), a signalé la vente de 15 226 actions ordinaires le 16/09/2025 à un prix de $4.37 par action. Le dépôt indique 415 156,55 actions en tant que propriété bénéficiaire directe après la transaction et indique un intérêt indirect de 23 250 019 actions détenu par ABP Trust, dont M. Portnoy est le seul fiduciaire; il déclare renoncer à la propriété bénéficiaire à l’exception de son intérêt pécuniaire. Le dépôt décrit le code de vente comme F, reflétant la retenue des actions pour satisfaire une obligation fiscale résultant de la vesting. Le Formulaire 4 a été signé le 18/09/2025.
Adam D. Portnoy, Direktor der Diversified Healthcare Trust (NASDAQ: DHC), meldete den Verkauf von 15.226 Stammaktien am 16.09.2025 zu einem Kurs von $4.37 pro Aktie. Die Einreichung verzeichnet 415.156,55 Aktien als direkte wohltätige Eigentümerschaft nach der Transaktion und gibt ein indirektes Interesse von 23.250.019 Aktien an, das von der ABP Trust gehalten wird, für den Portnoy alleiniger Treuhänder ist; er verzichtet auf wirtschaftliches Eigentum außerhalb seines finanziellen Interesses. Die Einreichung erklärt den Verkaufs Code als F, der die Zurückhaltung von Aktien zur Begleichung einer steuerlichen Verpflichtung aufgrund der Vesting widerspiegelt. Das Formular 4 wurde am 18.09.2025 unterzeichnet.
آدام د. بورنوي، مدير في Diversified Healthcare Trust (ناسداك: DHC)، أبلغ عن بيع 15,226 سهماً عادياً في 16/09/2025 بسعر $4.37 للسهم. تشير الوثيقة إلى 415,156.55 سهماً كملكية مباشرة مستفيدة بعد الصفقة وتوضح وجود مصالح غير مباشرة من 23,250,019 سهماً مملوكة لـ ABP Trust، الذي يشغل السيد Portnoy فيه الوصي الوحيد؛ وهو يتنصل من الملكية المفيدة باستثناء مصلحته المالية. تشرح الوثيقة رمز البيع بـ F، الذي يعكس حجز الأسهم لتلبية التزام ضريبي ناتج عن الاستحقاق. وقع النموذج 4 في 18/09/2025.
Adam D. Portnoy,Diversified Healthcare Trust(纳斯达克代码:DHC)的董事,报告在< b>2025-09-16以每股$4.37的价格出售了15,226普通股。申报显示交易后其直接受益所有权为415,156.55股,并指出由ABP Trust持有的23,250,019股间接权益;Portnoy先生为其唯一受托人;他在可得经济利益范围之外否认实际所有权。申报将出售代码解释为F,表示为满足税务义务而扣留股票。Form 4 于2025-09-18签署。
- Timely disclosure of insider sale under Section 16
- Sale clearly explained as tax-withholding related to vesting (Transaction Code F)
- Indirect holdings disclosed showing transparency about material trust ownership
- Director sold shares which could be perceived negatively by some investors despite tax explanation
- Indirect trust holds 23,250,019 shares where the reporter disclaims beneficial ownership except to pecuniary interest, leaving limited clarity on control extent
Insights
TL;DR: Routine insider withholding sale disclosed; large indirect trust holdings noted.
The reported transaction is a common administrative sale where shares are withheld to cover taxes on vested securities, as indicated by Transaction Code F and the filing explanation. This reduces direct holdings modestly while leaving a substantial indirect position via ABP Trust. From a governance perspective, timely filing and clear attribution of indirect holdings align with disclosure best practices. The trustee relationship to ABP Trust is disclosed but Mr. Portnoy explicitly disclaims beneficial ownership beyond his pecuniary interest, which is standard language for trust-held shares.
TL;DR: Small sale size and tax-withholding rationale make this a neutral, non-material insider event.
The sale of 15,226 shares at $4.37 appears administrative rather than an investment signal given the stated tax-withholding purpose. Direct ownership reported after the sale is shown as 415,156.55 shares while indirect holdings of 23,250,019 shares through ABP Trust remain significant; the filing does not quantify Mr. Portnoy’s pecuniary interest in the trust. There is no indication of derivative transactions or other material changes to overall insider exposure beyond this withholding action.
Adam D. Portnoy, direttore della Diversified Healthcare Trust (NASDAQ: DHC), ha segnalato la vendita di 15.226 azioni ordinarie il 16/09/2025 al prezzo di $4.37 per azione. La dichiarazione mostra 415.156,55 azioni come sua proprietà diretta beneficiaria dopo la transazione e indica un interesse indiretto di 23.250.019 azioni detenuto da ABP Trust, per le quale il signor Portnoy è unico fiduciario; egli disconosce la proprietà benefica salvo in quanto riguarda il proprio interesse pecuniario. La dichiarazione spiega il codice di vendita come F, che riflette la trattenuta di azioni per soddisfare un obbligo fiscale derivante dalla vestizione. Il Form 4 è stato firmato il 18/09/2025.
Adam D. Portnoy, director de Diversified Healthcare Trust (NASDAQ: DHC), informó la venta de 15.226 acciones comunes el 16/09/2025 a un precio de $4.37 por acción. La declaración señala 415.156,55 acciones como su propiedad directa y beneficiosa tras la operación e indica un interés indirecto de 23.250.019 acciones en ABP Trust, del cual el Sr. Portnoy es el fiduciario único; él renuncia a la propiedad beneficiosa salvo en la medida de su interés pecuniario. La declaración explica el código de venta como F, que refleja la retención de acciones para satisfacer una obligación tributaria derivada de la vesting. El Form 4 fue firmado el 18/09/2025.
Adam D. Portnoy, Diversified Healthcare Trust(NASDAQ: DHC)의 이사로, 15,226주의 일반주를 2025-09-16에 매도했다고 보고했습니다. 주당 매매가 $4.37입니다. 보고서에 매매 이후 그의 직접적 유익소유로 415,156.55주가 기재되었으며, 포트노이가 단독 수탁자인 ABP 트러스트가 보유한 간접적 이해관계 23,250,019주가 표시됩니다. 그는 재정적 이해관계 범위 밖에서 실질적 소유권을 포기합니다. 보고서는 매도 코드를 F로 설명하는데, 이는 과세 부채를 충당하기 위해 주식을 보류했음을 나타냅니다. 양식 4는 2025-09-18에 서명되었습니다.
Adam D. Portnoy, administrateur de Diversified Healthcare Trust (NASDAQ: DHC), a signalé la vente de 15 226 actions ordinaires le 16/09/2025 à un prix de $4.37 par action. Le dépôt indique 415 156,55 actions en tant que propriété bénéficiaire directe après la transaction et indique un intérêt indirect de 23 250 019 actions détenu par ABP Trust, dont M. Portnoy est le seul fiduciaire; il déclare renoncer à la propriété bénéficiaire à l’exception de son intérêt pécuniaire. Le dépôt décrit le code de vente comme F, reflétant la retenue des actions pour satisfaire une obligation fiscale résultant de la vesting. Le Formulaire 4 a été signé le 18/09/2025.
Adam D. Portnoy, Direktor der Diversified Healthcare Trust (NASDAQ: DHC), meldete den Verkauf von 15.226 Stammaktien am 16.09.2025 zu einem Kurs von $4.37 pro Aktie. Die Einreichung verzeichnet 415.156,55 Aktien als direkte wohltätige Eigentümerschaft nach der Transaktion und gibt ein indirektes Interesse von 23.250.019 Aktien an, das von der ABP Trust gehalten wird, für den Portnoy alleiniger Treuhänder ist; er verzichtet auf wirtschaftliches Eigentum außerhalb seines finanziellen Interesses. Die Einreichung erklärt den Verkaufs Code als F, der die Zurückhaltung von Aktien zur Begleichung einer steuerlichen Verpflichtung aufgrund der Vesting widerspiegelt. Das Formular 4 wurde am 18.09.2025 unterzeichnet.